163 related articles for article (PubMed ID: 25866341)
1. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
Bryant D; Hibbitts S; Almonte M; Tristram A; Fiander A; Powell N
J Clin Virol; 2015 May; 66():66-71. PubMed ID: 25866341
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
3. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.
Lorincz AT; Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Castanon A; Fiander A; Powell N; Tristram A; Cuzick J; Sasieni P
Int J Cancer; 2013 Aug; 133(3):637-44. PubMed ID: 23335178
[TBL] [Abstract][Full Text] [Related]
4. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
5. High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.
Norman I; Hjerpe A; Andersson S
Oncol Rep; 2013 Aug; 30(2):695-700. PubMed ID: 23756570
[TBL] [Abstract][Full Text] [Related]
6. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
8. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.
Bowden SJ; Kalliala I; Veroniki AA; Arbyn M; Mitra A; Lathouras K; Mirabello L; Chadeau-Hyam M; Paraskevaidis E; Flanagan JM; Kyrgiou M
EBioMedicine; 2019 Dec; 50():246-259. PubMed ID: 31732479
[TBL] [Abstract][Full Text] [Related]
9. Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Brandsma JL; Harigopal M; Kiviat NB; Sun Y; Deng Y; Zelterman D; Lizardi PM; Shabanova VS; Levi A; Yaping T; Hu X; Feng Q
Cancer Prev Res (Phila); 2014 May; 7(5):526-33. PubMed ID: 24556390
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
[TBL] [Abstract][Full Text] [Related]
12. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
[TBL] [Abstract][Full Text] [Related]
13. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
15. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
16. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
[TBL] [Abstract][Full Text] [Related]
17. Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.
Yang-Chun F; Zhen-Zhen C; Yan-Chun H; Xiu-Min M
Medicine (Baltimore); 2017 Jun; 96(25):e7270. PubMed ID: 28640134
[TBL] [Abstract][Full Text] [Related]
18. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression.
Kalantari M; Chase DM; Tewari KS; Bernard HU
J Med Virol; 2010 Feb; 82(2):311-20. PubMed ID: 20029805
[TBL] [Abstract][Full Text] [Related]
19. Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Rong S; Okunieff P; Zhang L; Li X
J Virol Methods; 2015 Nov; 224():35-41. PubMed ID: 26297960
[TBL] [Abstract][Full Text] [Related]
20. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
